SCHEMBL20172643

SCHEMBL20172643

CCc1ccc(SN2CCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
ATM Q13315 1/20 0.41
POLB P06746 1/20 0.39
RAB9A P51151 6/20 0.39
NPC1 O15118 5/20 0.39
CYP2A6 P11509 1/20 0.38
MGLL Q99685 1/20 0.37
HRH3 Q9Y5N1 3/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
TP53 P04637 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23844179 0.82 HRH3 (0.44) SMN1; SMN2KMT2AKDM4EMEN1ATM
SCHEMBL24947598 0.74 PRMT6 (0.41) KDM4EHRH3TAAR1MAPTCYP2D6
SCHEMBL21613839 0.74 HRH3 (0.39) SMN1; SMN2KMT2AKDM4EMEN1ATM
SCHEMBL18583232 0.72 HPGD (0.43) SMN1; SMN2KMT2AMEN1POLBRAB9A
SCHEMBL20311368 0.72 MAOB (0.38) SMN1; SMN2KMT2AKDM4EMEN1POLB
SCHEMBL21991191 0.72 SMN1; SMN2 (0.43) SMN1; SMN2KMT2AKDM4EMEN1RAB9A
SCHEMBL24715763 0.68 KDM4E (0.57) KMT2AKDM4EMEN1RAB9ANPC1
SCHEMBL15721254 0.68 MAPK1 (0.44) KMT2AKDM4EMEN1POLBRAB9A
SCHEMBL19903214 0.68 HPGD (0.39) SMN1; SMN2KMT2AMEN1ATMRAB9A
SCHEMBL19274519 0.68 ALDH1A1 (0.32) MGLLMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3323814-A1 (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE I INHIBITORS AstraZeneca AB (SE) 2018-05-23 EP disclosed